TY - JOUR
T1 - Coreceptor tropism in human immunodeficiency virus type 1 subtype D
T2 - High prevalence of CXCR4 tropism and heterogeneous composition of viral populations
AU - Huang, Wei
AU - Eshleman, Susan H.
AU - Toma, Jonathan
AU - Fransen, Signe
AU - Stawiski, Eric
AU - Paxinos, Ellen E.
AU - Whitcomb, Jeannette M.
AU - Young, Alicia M.
AU - Donnell, Deborah
AU - Mmiro, Francis
AU - Musoke, Philippa
AU - Guay, Laura A.
AU - Jackson, J. Brooks
AU - Parkin, Neil T.
AU - Petropoulos, Christos J.
PY - 2007/8
Y1 - 2007/8
N2 - In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from ∼20% in early infection to ∼50% in advanced disease. Coreceptor use by non-subtype B HIV is less well characterized. We studied coreceptor tropism of subtype A and D HIV-1 collected from 68 pregnant, antiretroviral drug-naive Ugandan women (HIVNET 012 trial). None of 33 subtype A or 10 A/D-recombinant viruses used the CXCR4 coreceptor. In contrast, nine (36%) of 25 subtype D viruses used both CXCR4 and CCR5 coreceptors. Clonal analyses of the nine subtype D samples with dual or mixed tropism revealed heterogeneous viral populations comprised of X4-, R5-, and dual-tropic HIV-1 variants. In five of the six samples with dual-tropic strains, V3 loop sequences of dual-tropic clones were identical to those of cocirculating R5-tropic clones, indicating the presence of CXCR4 tropism determinants outside of the V3 loop. These dual-tropic variants with R5-tropic-like V3 loops, which we designated "dual-R," use CCR5 much more efficiently than CXCR4, in contrast to dual-tropic clones with X4-tropic-like V3 loops ("dual-X") . These observations have implications for pathogenesis and treatment of subtype D-infected individuals, for the association between V3 sequence and coreceptor tropism phenotype, and for understanding potential mechanisms of evolution from exclusive CCR5 use to efficient CXCR4 use by subtype D HIV-1.
AB - In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from ∼20% in early infection to ∼50% in advanced disease. Coreceptor use by non-subtype B HIV is less well characterized. We studied coreceptor tropism of subtype A and D HIV-1 collected from 68 pregnant, antiretroviral drug-naive Ugandan women (HIVNET 012 trial). None of 33 subtype A or 10 A/D-recombinant viruses used the CXCR4 coreceptor. In contrast, nine (36%) of 25 subtype D viruses used both CXCR4 and CCR5 coreceptors. Clonal analyses of the nine subtype D samples with dual or mixed tropism revealed heterogeneous viral populations comprised of X4-, R5-, and dual-tropic HIV-1 variants. In five of the six samples with dual-tropic strains, V3 loop sequences of dual-tropic clones were identical to those of cocirculating R5-tropic clones, indicating the presence of CXCR4 tropism determinants outside of the V3 loop. These dual-tropic variants with R5-tropic-like V3 loops, which we designated "dual-R," use CCR5 much more efficiently than CXCR4, in contrast to dual-tropic clones with X4-tropic-like V3 loops ("dual-X") . These observations have implications for pathogenesis and treatment of subtype D-infected individuals, for the association between V3 sequence and coreceptor tropism phenotype, and for understanding potential mechanisms of evolution from exclusive CCR5 use to efficient CXCR4 use by subtype D HIV-1.
UR - http://www.scopus.com/inward/record.url?scp=34547128097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547128097&partnerID=8YFLogxK
U2 - 10.1128/JVI.00218-07
DO - 10.1128/JVI.00218-07
M3 - Article
C2 - 17507467
AN - SCOPUS:34547128097
SN - 0022-538X
VL - 81
SP - 7885
EP - 7893
JO - Journal of virology
JF - Journal of virology
IS - 15
ER -